TM UBS (UK) - UK Equity C GBP IncomeRegister to Unlock Ratings |
Performance History | 31/10/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 82.1 | 16.4 | -2.3 | 6.5 | 8.5 | |
+/-Cat | 91.2 | -1.6 | -0.3 | -1.7 | 1.2 | |
+/-B’mrk | - | - | - | -1.1 | 0.3 | |
Category: UK Large-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 21/11/2024 | GBX 166.00 | |
Day Change | 0.42% | |
Morningstar Category™ | UK Large-Cap Equity | |
IA (formerly IMA) Sector | - | |
ISIN | GB00B6932K51 | |
Fund Size (Mil) 30/11/2009 | GBP 9.84 | |
Share Class Size (Mil) 21/11/2024 | GBP 0.01 | |
Max Initial Charge | 5.25% | |
Ongoing Charge 31/08/2024 | 1.45% |
Investment Objective: TM UBS (UK) - UK Equity C GBP Income |
To provide capital growth net of fees from a portfolio of investments over the longer term (5 year rolling period). The Fund will invest principally (85-100%) in UK equities (defined as companies incorporated, domiciled or with a significant proportion of their business in the UK), and the Fund may also invest in global equities (0- 15%), with a view to maximising potential returns. Equity investment will normally be made by direct investment, however the Fund may also invest indirectly (up to 15%) via collective investment vehicles (including those managed or operated by the ACD or its associate). |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Gareth Thomas 16/05/2012 | ||
Inception Date 15/02/2011 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
IA UK All Companies | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for TM UBS (UK) - UK Equity C GBP Income | 30/09/2024 |
|
|
Top 5 Holdings | Sector | % |
RELX PLC | Industrials | 8.66 |
AstraZeneca PLC | Healthcare | 6.45 |
Shell PLC | Energy | 6.27 |
SSE PLC | Utilities | 4.83 |
Compass Group PLC | Consumer Cyclical | 4.52 |
Increase Decrease New since last portfolio | ||
TM UBS (UK) - UK Equity C GBP Income |